Product image of Fanhdi (Human Coagulation Factor Viii, Human Von Willebrand Factor) supplied by GNH India

Fanhdi

Active Ingredient:
Human Coagulation Factor Viii, Human Von Willebrand Factor
Origin:
EU

Fanhdi (Human Coagulation Factor Viii, Human Von Willebrand Factor)

Fanhdi is a medication containing human coagulation factor VIII and von Willebrand factor, used to manage bleeding disorders. This intravenous treatment supports blood clotting and is manufactured by Instituto Grifols, S.A.

Manufacturer / TM Owner

Instituto Grifols, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Fanhdi is primarily used to treat bleeding episodes in individuals with hemophilia A and von Willebrand disease. It works by replacing the missing clotting factors in the blood, helping to control and prevent bleeding. This medication is often used in situations where rapid clotting is necessary, such as during surgery or after an injury.

Side Effects

  • Common effects of Fanhdi may include mild reactions at the injection site, such as redness or swelling. Some users might experience flu-like symptoms, including fever or chills. Severe allergic reactions are rare but possible and require immediate medical attention.

Precautions & Warnings

  • Fanhdi should be administered under the supervision of a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions before use. Proper storage and handling are crucial to maintain the effectiveness of the medication.

Avoid Interactions

  • Fanhdi may interact with certain medications, including those that affect blood clotting. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances that affect blood clotting should be used with caution.

Frequently Asked Questions

Fanhdi is used to manage bleeding episodes in individuals with hemophilia A and von Willebrand disease.

Fanhdi is administered intravenously, typically under the supervision of a healthcare professional.

Common side effects may include mild reactions at the injection site, such as redness or swelling, and flu-like symptoms.

Yes, Fanhdi is often used during surgery to help control bleeding in individuals with bleeding disorders.

The safety of Fanhdi for long-term use should be discussed with a healthcare provider, as individual needs and conditions vary.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Coagulation Factor Viii, Human Von Willebrand Factor

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT